Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and MELAS Syndrome

n(g),n(g')-dimethyl-l-arginine has been researched along with MELAS Syndrome in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

MELAS Syndrome: A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117)

Research Excerpts

ExcerptRelevanceReference
"Based on the hypothesis that mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) are caused by impaired vasodilation in an intracerebral artery, the authors evaluated the effects of administering l-arginine, a nitric oxide precursor."9.11L-arginine improves the symptoms of strokelike episodes in MELAS. ( Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S, 2005)
"Based on the hypothesis that mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) are caused by impaired vasodilation in an intracerebral artery, the authors evaluated the effects of administering l-arginine, a nitric oxide precursor."5.11L-arginine improves the symptoms of strokelike episodes in MELAS. ( Akita, Y; Fujimoto, S; Koga, Y; Matsuishi, T; Nishioka, J; Povalko, N; Tanabe, Y; Yatsuga, S, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koga, Y1
Akita, Y1
Nishioka, J1
Yatsuga, S1
Povalko, N1
Tanabe, Y1
Fujimoto, S1
Matsuishi, T1

Trials

1 trial available for n(g),n(g')-dimethyl-l-arginine and MELAS Syndrome

ArticleYear
L-arginine improves the symptoms of strokelike episodes in MELAS.
    Neurology, 2005, Feb-22, Volume: 64, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Amino Acids; Arginine; Cerebral Arteries; Child; Child, Pre

2005